2022
DOI: 10.3390/polym14163263
|View full text |Cite
|
Sign up to set email alerts
|

Design and Immunoinformatic Assessment of Candidate Multivariant mRNA Vaccine Construct against Immune Escape Variants of SARS-CoV-2

Abstract: To effectively counter the evolving threat of SARS-CoV-2 variants, modifications and/or redesigning of mRNA vaccine construct are essentially required. Herein, the design and immunoinformatic assessment of a candidate novel mRNA vaccine construct, DOW-21, are discussed. Briefly, immunologically important domains, N-terminal domain (NTD) and receptor binding domain (RBD), of the spike protein of SARS-CoV-2 variants of concern (VOCs) and variants of interest (VOIs) were assessed for sequence, structure, and epit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 80 publications
0
7
0
Order By: Relevance
“…Addressing the growing concern of SARS-CoV-2 variants, Hussain et al [33] unveiled DOW-21, a restructured mRNA vaccine construct. This design emphasizes the N-terminal domain (NTD) and the receptor-binding domain (RBD) of the spike protein, integrating variations from both variants of concern (VOCs) and variants of interest (VOIs).…”
Section: Overview Of Reverse Vaccinology In Mrna Vaccine Designmentioning
confidence: 99%
See 4 more Smart Citations
“…Addressing the growing concern of SARS-CoV-2 variants, Hussain et al [33] unveiled DOW-21, a restructured mRNA vaccine construct. This design emphasizes the N-terminal domain (NTD) and the receptor-binding domain (RBD) of the spike protein, integrating variations from both variants of concern (VOCs) and variants of interest (VOIs).…”
Section: Overview Of Reverse Vaccinology In Mrna Vaccine Designmentioning
confidence: 99%
“…The Virus Pathogen Database and Analysis Resource (ViPR) serves as another specialized repository with a focus on viral pathogens. Studies cited as Ahammad and Lira [27], ELKHOLY [28] leveraged ViPR for the purpose of sequence acquisition, whereas the Global Initiative for Sharing All Influenza Data (GISAID) was utilized in Oluwagbemi et al [30], Oladipo et al [32], Hussain et al [33] for the procurement of complete genomic sequences of SARS-CoV-2 and its associated variants. GISAID is particularly renowned for its expeditious data dissemination capabilities, rendering it indispensable for research endeavors necessitating real-time genomic data.…”
Section: Retrieval Of Sequencementioning
confidence: 99%
See 3 more Smart Citations